Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)

NCT05507450 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1271

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue Disease
Dengue Virus

Interventions

BIOLOGICAL: V181 High-Potency Level
BIOLOGICAL: V181 Mid-Potency Level
BIOLOGICAL: V181 Low-Potency Level
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC